Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH.
Jonathan G StineGloriany RivasBreianna HummerAndrés Duarte-RojoChristine N MayNathaniel G GeyerVernon M ChinchilliDavid E ConroyEllen Siobhan MitchellMeaghan McCallumAndreas MichealidesKathryn H SchmitzPublished in: Hepatology communications (2023)
This clinical trial demonstrated that NW is not only feasible, acceptable, and safe but also highly efficacious because this mHealth lifestyle intervention program led to significantly greater body weight loss than standard clinical care. Future large-scale studies are required to validate these findings with more representative samples and to determine if mHealth lifestyle intervention programs can lead to sustained, long-term weight loss in patients with NASH.
Keyphrases
- weight loss
- bariatric surgery
- randomized controlled trial
- body weight
- roux en y gastric bypass
- quality improvement
- clinical trial
- gastric bypass
- metabolic syndrome
- healthcare
- physical activity
- cardiovascular disease
- glycemic control
- palliative care
- weight gain
- study protocol
- public health
- type diabetes
- adipose tissue
- pain management
- skeletal muscle
- affordable care act